Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) — Detroit, Michigan

Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) has participated in 2 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma, Carcinoma, Adenocarcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Dept.of KarmanosCancerInst (5)?

Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) conducted?

Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) has 2 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma, Carcinoma, Adenocarcinoma.

Is Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) accredited by Crixeo Health?

Karmanos Cancer Institute Dept.of KarmanosCancerInst (5) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Dept.of KarmanosCancerInst (5)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.